GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Gross Margin %

Embla Medical hf (OCSE:EMBLA) Gross Margin % : 60.26% (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Embla Medical hf's Gross Profit for the three months ended in Mar. 2024 was kr826 Mil. Embla Medical hf's Revenue for the three months ended in Mar. 2024 was kr1,371 Mil. Therefore, Embla Medical hf's Gross Margin % for the quarter that ended in Mar. 2024 was 60.26%.


The historical rank and industry rank for Embla Medical hf's Gross Margin % or its related term are showing as below:

OCSE:EMBLA' s Gross Margin % Range Over the Past 10 Years
Min: 61.19   Med: 62.91   Max: 63.92
Current: 61.42


During the past 13 years, the highest Gross Margin % of Embla Medical hf was 63.92%. The lowest was 61.19%. And the median was 62.91%.

OCSE:EMBLA's Gross Margin % is ranked better than
62.06% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs OCSE:EMBLA: 61.42

Embla Medical hf had a gross margin of 60.26% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Embla Medical hf was -0.60% per year.


Embla Medical hf Gross Margin % Historical Data

The historical data trend for Embla Medical hf's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Gross Margin % Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.92 62.15 63.37 61.19 61.80

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.83 62.55 61.70 61.16 60.26

Competitive Comparison of Embla Medical hf's Gross Margin %

For the Medical Devices subindustry, Embla Medical hf's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Gross Margin % falls into.



Embla Medical hf Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Embla Medical hf's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=3318.8 / 5369.986
=(Revenue - Cost of Goods Sold) / Revenue
=(5369.986 - 2051.192) / 5369.986
=61.80 %

Embla Medical hf's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=826.2 / 1370.945
=(Revenue - Cost of Goods Sold) / Revenue
=(1370.945 - 544.785) / 1370.945
=60.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Embla Medical hf  (OCSE:EMBLA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Embla Medical hf had a gross margin of 60.26% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Embla Medical hf Gross Margin % Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines